Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country (Q35211424)

7 August 2017

title

Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country (English)

1 reference

7 August 2017

0 references

1 reference

4

Catherine Dollfus

0 references

author name string

Clement Taron-Brocard

1

1 reference

7 August 2017

Jerome Le Chenadec

2

1 reference

7 August 2017

Albert Faye

3

1 reference

7 August 2017

Catherine Dollfus

4

1 reference

7 August 2017

Tessa Goetghebuer

5

1 reference

7 August 2017

Vincent Gajdos

6

1 reference

7 August 2017

Jean-Marc Labaune

7

1 reference

7 August 2017

Anais Perilhou

8

1 reference

7 August 2017

Laurent Mandelbrot

9

1 reference

7 August 2017

Stephane Blanche

10

1 reference

7 August 2017

Josiane Warszawski

11

1 reference

7 August 2017

France REcherche Nord&Sud Sida-HIV Hepatites - Enquete Perinatale Francaise - CO1/CO11 Study Group

12

1 reference

7 August 2017

language of work or name

English

0 references

publication date

22 July 2014

1 reference

Clinical Infectious Diseases

7 August 2017

published in

1 reference

7 August 2017

volume

59

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

1332-1345

1 reference

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Child mortality according to maternal and infant HIV status in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Mortality and health outcomes of HIV-exposed and unexposed children in a PMTCT cohort in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

High rates of all-cause and gastroenteritis-related hospitalization morbidity and mortality among HIV-exposed Indian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

HIV-exposed uninfected children: a growing population with a vulnerable immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Reduced thymic size but no evidence of impaired thymic function in uninfected children born to human immunodeficiency virus-infected mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Altered innate immune development in HIV-exposed uninfected infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Impaired humoral response to vaccines among HIV-exposed uninfected infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Placental antibody transfer: influence of maternal HIV infection and placental malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Evidence of impact of maternal HIV infection on immunoglobulin levels in HIV-exposed uninfected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Infectious Disease Morbidity Among Young HIV-1-Exposed But Uninfected Infants in Latin American and Caribbean Countries: The National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Increased CD154 Expression in Uninfected Infants Born to HIV-Positive Mothers Exposed to Antiretroviral Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Immune activation and normal levels of endogenous antivirals are seen in healthy adolescents born of HIV-infected mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

Effect of Perinatal Antiretroviral Drug Exposure on Hematologic Values in HIV‐Uninfected Children: An Analysis of the Women and Infants Transmission Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU586

21 January 2018

Identifiers

DOI

10.1093/CID/CIU586

1 reference

7 August 2017

1 reference